Company intelligence / Profile preview

New York Blood Center

New York City, New York, USAnybc.org ↗

Ownership: Private
Development stage: Commercial

Overview

New York Blood Center provides essential blood products to over 500 hospitals nationwide and has pioneered programs such as convalescent plasma collection during the COVID‑19 pandemic. It also operates advanced laboratories focused on precision genomics testing to improve transfusion outcomes.

Therapeutic areas: Infectious DiseasesHematology
Modalities: Biologic (blood products)Cell therapy (stem cell services)Plasma therapy (convalescent plasma for infectious diseases)
Industry: Biotech

Drug pipeline

8 assets

cord blood unit

Approved

7 more assets in the full pipeline.

Request access →

Partnerships

Mayo Clinic (COVID convalescent plasma research validation)Various hospital systems (>500 served nationally)

Beyond the preview

Go deeper on New York Blood Center.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on New York Blood Center.

Explore the full profile